COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 2855: Articles 28541-28550  | Next

Management and Outcomes of ST-segment Elevation Myocardial Infarction During Coronavirus 2019 Pandemic in a Center with 24/7 Primary Angioplasty Capability: Should We Change Our Practice During Outbreak?
Salarifar, M., Ghavami, M., Poorhosseini, H., Masoudkabir, F., Jenab, Y., Amirzadegan, A., Alidoosti, M., Aghajani, H., Bozorgi, A., Hosseini, K., Lotfi-Tokaldany, M., Mortazavi, S. H., Aein, A., Ahmadian, T., Sadeghian, S.
10.1101/2020.05.02.20088302 — Posted: 2020-05-06
Is Hydroxychloroquine Safe During Pregnancy? Observations from Penn Medicine
Davidson, L., Canelon, S., Boland, M. R.
10.1101/2020.04.29.20085621 — Posted: 2020-05-06
COVID-19 Pandemic Prediction for Hungary; a Hybrid Machine Learning Approach
pinter, g., Felde, I., MOSAVI, A., Ghamisi, P., Gloaguen, R.
10.1101/2020.05.02.20088427 — Posted: 2020-05-06
30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study
Giacomelli, A., Ridolfo, A. L., Milazzo, L., Oreni, L., Bernacchia, D., Siano, M., Bonazzetti, C., Schiuma, M., Covizzi, A., Passerini, M., Piscaglia, M., Coen, M., Gubertini, G., Rizzardini, G., Cogliati, C., Brambilla, A. M., Colombo, R., Castelli, A., Rech, R., Riva, A., Torre, A., Meroni, L., Rusconi, S., Antinori, S., Galli, M.
10.1101/2020.05.02.20088336 — Posted: 2020-05-06
Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: Study Protocol for a Pragmatic Randomized Controlled Trial
Lother, S. A., Abassi, M., Agostinis, A., Bangdiwala, A. S., Cheng, M. P., Drobot, G., Engen, N., Hullsiek, K. H., Kelly, L. E., Lee, T. C., Lofgren, S. M., MacKenzie, L. J., Marten, N., McDonald, E. G., Okafor, E. C., Pastick, K. A., Pullen, M. F., Rajasingham, R., Schwartz, I., Skipper, C. P., Turgeon, A. F., Zarychanski, R., Boulware, D. R.
10.1101/2020.05.01.20087999 — Posted: 2020-05-06
Model of a Testing-and-Quarantine Strategy to Slow-Down the COVID-19 Outbreak in Guadeloupe
ALLALI, M., PORTECOP, P., CARLES, M., GIBERT, D.
10.1101/2020.05.01.20088138 — Posted: 2020-05-06
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis
Pinto, A. C. P. N., Rocha, A. P., Milby, K. M. M., Rocha Filho, C. R., Reis, F. S. A., Carvas Junior, N., Civile, V. T., Santos, R. R. P., Trevisani, G. F. M., Ferla, L. J., Ramalho, G. S., Puga, M. E. S., Trevisani, V. F. M., Atallah, A. N.
10.1101/2020.05.02.20088823 — Posted: 2020-05-06
Impact of non-pharmaceutical interventions against COVID-19 in Europe: a quasi-experimental study
Hunter, P. R., Colon-Gonzalez, F., Brainard, J. S., Rushton, S.
10.1101/2020.05.01.20088260 — Posted: 2020-05-06 Discussion: Onsite
Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in environmental specimens via surface enhanced Raman scattering (SERS)
Zhang, D., Zhang, X., Ma, R., Deng, S., Wang, X., Zhang, X., Huang, X., Liu, Y., Li, G., Qu, J., Zhu, Y., Li, J.
10.1101/2020.05.02.20086876 — Posted: 2020-05-06 Discussion: Offsite
A strategy for finding people infected with SARS-CoV-2: optimizing pooled testing at low prevalence
Mutesa, L., Ndishimye, P., Butera, Y., Uwineza, A., Rutayisire, R., Musoni, E., Rujeni, N., Nyatanyi, T., Ntagwabira, E., Semakula, M., Musanabaganwa, C., Nyamwasa, D., Ndashimye, M., Ujeneza, E., Mwikarago, I. E., Muvunyi, C. M., Mazarati, J. B., Nsanzimana, S., Turok, N., Ndifon, W.
10.1101/2020.05.02.20087924 — Posted: 2020-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).